Lista de

cyclophosphamide
28
"Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes" (2014) Castro, C.N.;Barcala Tabarrozzi, A.E.;Winnewisser, J. (...)Perone, M.J. Clinical and Experimental Immunology. 177(1):149-160
"The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide" (2012) Zacarías Fluck, M.F.;Hess, L.;Salatino, M. (...)Scharovsky, O.G. Cancer Immunology, Immunotherapy. 61(4):469-480
"The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide" (2012) Zacarías Fluck, M.F.;Hess, L.;Salatino, M. (...)Scharovsky, O.G. Cancer Immunology, Immunotherapy. 61(4):469-480
"The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide" (2012) Zacarías Fluck, M.F.;Hess, L.;Salatino, M. (...)Scharovsky, O.G. Cancer Immunology, Immunotherapy. 61(4):469-480
"Key questions in metastasis: New insights in molecular pathways and therapeutic implications" (2011) Gueron, G.; de Siervi, A.; Vazquez, E. Current Pharmaceutical Biotechnology. 12(11):1867-1880
"Molecular mechanisms of action of some immunosuppresive drugs " (2008) Liberman, A.C.; Druker, J.; Refojo, D.; Arzt, E. Medicina. 68(6):455-464
"Clinical significance of anti-Ro antibodies in rheumatoid arthritis" (2008) Schneeberger, E.; Citera, G.; Heredia, M.; Cocco, J.M. Clinical Rheumatology. 27(4):517-519
"Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer" (2008) Salatino, M.;Croci, D.O.;Bianco, G.A. (...)Rabinovich, G.A. Expert Opinion on Biological Therapy. 8(1):45-57
"Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15" (1998) Ballaré, C.;Portela, P.;Schiaffi, J. (...)Mordoh, J. Breast Cancer Research and Treatment. 47(2):163-170
"Potentiation of the 5-aminolevulinic acid-based photodynamic therapy with cyclophosphamide" (1997) Casas, A.; Fukuda, H.; Batlle, A.M.D.C. Cancer Biochemistry Biophysics. 16(1):183-196
"Potentiation of the 5-aminolevulinic acid-based photodynamic therapy with cyclophosphamide" (1997) Casas, A.; Fukuda, H.; Batlle, A.M.D.C. Cancer Biochemistry Biophysics. 16(1):183-196
"Potentiation of the 5-aminolevulinic acid-based photodynamic therapy with cyclophosphamide" (1997) Casas, A.; Fukuda, H.; Batlle, A.M.D.C. Cancer Biochemistry Biophysics. 16(1):183-196
"Evaluation of the porphyrinogenic risk of antineoplastics" (1997) Cochón, A.C.; Aldonatti, C.; San Martín De Viale, L.C.; De Calmanovici, R.W. Journal of Applied Toxicology. 17(3):171-177
"Evaluation of the porphyrinogenic risk of antineoplastics" (1997) Cochón, A.C.; Aldonatti, C.; San Martín De Viale, L.C.; De Calmanovici, R.W. Journal of Applied Toxicology. 17(3):171-177
"Metabolic changes in the heme pathway driven by cyclophosphamide treatment in mice." (1997) Casas, A.; Fukuda, H.; Del C Batlle, A.M. Cellular and molecular biology (Noisy-le-Grand, France). 43(1):95-101
"Metabolic changes in the heme pathway driven by cyclophosphamide treatment in mice." (1997) Casas, A.; Fukuda, H.; Del C Batlle, A.M. Cellular and molecular biology (Noisy-le-Grand, France). 43(1):95-101
"Sequential development of 2 connective tissue diseases in juvenile patients" (1993) Citera, G.; Espada, G.; Maldonado Cocco, J.A. Journal of Rheumatology. 20(12):2149-2152
"Cyclophosphamide and its metabolite acrolein. Some studies on their porphyrinogenic action in 17 day old chick embryo." (1992) Cochón, A.C.; San Martín de Viale, L.C.; Wainstok de Calmanovici, R. Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology. 102(1):143-148
"Cyclophosphamide and its metabolite acrolein. Some studies on their porphyrinogenic action in 17 day old chick embryo." (1992) Cochón, A.C.; San Martín de Viale, L.C.; Wainstok de Calmanovici, R. Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology. 102(1):143-148
"Cyclophosphamide and its metabolite acrolein. Some studies on their porphyrinogenic action in 17 day old chick embryo" (1992) Cochón, A.C.; de Viale, L.C.S.M.; de Calmanovici, R.W. Comparative Biochemistry and Physiology. Part C, Comparative. 102(1):143-148
"Cyclophosphamide and its metabolite acrolein. Some studies on their porphyrinogenic action in 17 day old chick embryo" (1992) Cochón, A.C.; de Viale, L.C.S.M.; de Calmanovici, R.W. Comparative Biochemistry and Physiology. Part C, Comparative. 102(1):143-148
"Cyclophosphamide and its metabolite acrolein. Some studies on their porphyrinogenic action in 17 day old chick embryo" (1992) Cochón, A.C.; de Viale, L.C.S.M.; de Calmanovici, R.W. Comparative Biochemistry and Physiology. Part C, Comparative. 102(1):143-148
"Tuberculous arthritis in the course of connective tissue disease: Report of 4 cases" (1992) Stecher, D.R.; Gusis, S.E.; Maldonado Cocco, J.A. Journal of Rheumatology. 19(9):1418-1420
"Effect of some antineoplasics on metabolic heme pathway" (1988) Wainstok De Calmanovici, R.; San Martin De Viale, L.C. International Journal of Biochemistry. 20(9):1015-1020
"Effect of some antineoplasics on metabolic heme pathway" (1988) Wainstok De Calmanovici, R.; San Martin De Viale, L.C. International Journal of Biochemistry. 20(9):1015-1020
"Effect of some antineoplasics on metabolic heme pathway" (1988) Wainstok De Calmanovici, R.; San Martin De Viale, L.C. International Journal of Biochemistry. 20(9):1015-1020